Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer-Reference-Cited by-同舟云学术

Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer

Published:2023-06 Issue:3 Volume:21 Page:383-392.e2
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

George Daniel J.,Saad Fred,Cookson Michael S.,Saltzstein Daniel R.,Tutrone Ronald,Bossi Alberto,Brown Bruce,Selby Bryan,Lu Sophia,Buckley David,Tombal Bertrand,Shore Neal D.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference28 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Androgen deprivation therapy as backbone therapy in the management of prostate cancer;Merseburger;Onco Targets Ther,2016

3. Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Parker;Ann Oncol,2015

4. Prostate cancer, National Comprehensive Cancer Network Clinical Practice guidelines in oncology. 2022. Version 1. 2023. Available at: NCCN.org. Accessed December 18, 2022.

5. Does oral antiandrogen use before luteinizing hormone-releasing hormone therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare?;Oh;Urology,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen Deprivation Therapy in Prostate Cancer: A Practical Approach to Complex Clinical Scenarios;EMJ Urology;2024-05-21

2. Comparison of the efficacy and safety profiles of generic and branded leuprorelin acetate microspheres in patients with prostate cancer;Oncology Letters;2024-05-14

3. Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy;Drug Safety;2024-04-12

4. Corrigendum;Clinical Genitourinary Cancer;2024-04

5. Comment je prescris le rélugolix, un nouvel antagoniste de la LHRH;Progrès en Urologie - FMC;2023-12